T. Rowe Price Associates
EYPT icon

T. Rowe Price Associates’s EyePoint Pharmaceuticals EYPT Stock Holding History

T. Rowe Price Associates’s Portfolio EYPT Stock Details EYPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$788K Sell
2025
Q1 		$7.34M Sell
2024
Q4 		$16M Sell
2024
Q3 		$19.9M Sell
2024
Q2 		$21.8M Buy
2024
Q1 		$51M Sell
2023
Q4 		$58.3M Buy
2023
Q3 		$11M Buy